Cargando…
NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor
The current standard of care for lung cancer consists of concurrent chemotherapy and radiation. Several studies have shown that the DNA-PKcs inhibitor NU7441 is a highly potent radiosensitizer, however, the mechanism of NU7441's anti-proliferation effect has not been fully elucidated. In this s...
Autores principales: | Yu, Lan, Shang, Zeng-Fu, Hsu, Feng-Ming, Zhang, Zhang, Tumati, Vasu, Lin, Yu-Fen, Chen, Benjamin P.C., Saha, Debabrata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414158/ https://www.ncbi.nlm.nih.gov/pubmed/25714019 |
Ejemplares similares
-
Effect of PF-02341066 and radiation on non-small cell lung cancer cells
por: TUMATI, VASU, et al.
Publicado: (2013) -
DNA-PKcs is required to maintain stability of Chk1 and Claspin for optimal replication stress response
por: Lin, Yu-Fen, et al.
Publicado: (2014) -
Inhibition of DNA-PKcs enhances radiosensitivity and increases the levels of ATM and ATR in NSCLC cells exposed to carbon ion irradiation
por: YANG, LINA, et al.
Publicado: (2015) -
Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high‐risk prostate cancer patients with worse survival following radiation therapy
por: Jacobs, Corbin, et al.
Publicado: (2015) -
KU-0060648 inhibits hepatocellular carcinoma cells through DNA-PKcs-dependent and DNA-PKcs-independent mechanisms
por: Chen, Min-Bin, et al.
Publicado: (2016)